Sector
HealthcareOpen
₹68.2Prev. Close
₹71.68Turnover(Lac.)
₹25.14Day's High
₹72.97Day's Low
₹68.252 Week's High
₹98.752 Week's Low
₹51.01Book Value
₹15.77Face Value
₹10Mkt Cap (₹ Cr.)
133.07P/E
51.57EPS
1.39Divi. Yield
59.35Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 18.76 | 18.76 | 18.76 | 18.76 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 90.45 | 43.2 | 59.21 | 67.86 |
Net Worth | 109.21 | 61.96 | 77.97 | 86.62 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 86.17 | 69.24 | 111.87 | 149.19 |
yoy growth (%) | 24.45 | -38.1 | -25.01 | 6.14 |
Raw materials | -17.02 | -14.05 | -21.31 | -33.06 |
As % of sales | 19.75 | 20.3 | 19.05 | 22.16 |
Employee costs | -18.52 | -18.18 | -21.45 | -21.54 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | -8.3 | -18.31 | -12.15 | 5.3 |
Depreciation | -12.53 | -12.87 | -12.53 | -4.21 |
Tax paid | 0 | 3.45 | 3.09 | -2.16 |
Working capital | -14.39 | 7.09 | -37.66 | 2.53 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 24.45 | -38.1 | -25.01 | 6.14 |
Op profit growth | -154.58 | 130.72 | -258.93 | 97.11 |
EBIT growth | -84.27 | 155.67 | -176.35 | 26.64 |
Net profit growth | 3.64 | -11.52 | -388.32 | 11.37 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 59.01 | 85.95 | 86.18 | 69.24 | 111.87 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 59.01 | 85.95 | 86.18 | 69.24 | 111.87 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 64.88 | 6.64 | 7.39 | 15.1 | 11.19 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,110.3 | 132.18 | 1,07,936.93 | 138.24 | 0.14 | 697.4 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,844.9 | 81.9 | 98,419.16 | 341.6 | 0.23 | 2,054.8 | 569.62 |
Fortis Healthcare Ltd FORTIS | 662.35 | 248.07 | 50,004.65 | 39.56 | 0.15 | 366.87 | 120.23 |
Narayana Hrudayalaya Ltd NH | 1,786.95 | 85.09 | 36,518.25 | 79.22 | 0.22 | 865.04 | 95.32 |
Global Health Ltd MEDANTA | 1,188.4 | 81.34 | 31,918.92 | 99.31 | 0 | 624.4 | 113.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Daljit Singh
Independent Director
Shailaja Chandra
Whole Time Director
Chandrasekar Ramasamy
Non Executive Director
RICHA SINGH DEBGUPTA
Independent Director
Suvalaxmi Chakraborty
Company Sec. & Compli. Officer
Vinti Verma
Non Executive Director
RITU GARG
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Fortis Malar Hospitals Ltd
Summary
Fortis Malar Hospital Limited (formerly known as Malar Hospital Limited) was established on April 13, 1989 to set up, manage and operate a multi-specialty hospital. The Company was changed to Fortis Malar Hospital Limited on December 21, 2010. The Hospital was acquired by Fortis Group in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services. With a total bed-strength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal MedicineAll the above departments are fully became operational under phase I of the project. The second phase of the project envisages enhacement of the number of beds from 100 to 250 beds at an cost of Rs.2120 lacs. To part the project the company came into rights issues during 1995. The Hospital have started performing Cardio Thoracic surgeries with effect from 13-10-2003. Dr.K M Cherian is leading this cardio Thoracic department. He has won several awards and honors including Padmashree award from the Government. Dr.K M Cherian has conducted around 26,200 cardio thoracic cases including infant heart surgery, heart transplants, paediatric heart transplants and heart and lung transplants. This type of surgery will
Read More
The Fortis Malar Hospitals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹71 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fortis Malar Hospitals Ltd is ₹133.07 Cr. as of 09 May ‘25
The PE and PB ratios of Fortis Malar Hospitals Ltd is 51.57 and 4.54 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Fortis Malar Hospitals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Fortis Malar Hospitals Ltd is ₹51.01 and ₹98.7 as of 09 May ‘25
Fortis Malar Hospitals Ltd's CAGR for 5 Years at 10.94%, 3 Years at 9.07%, 1 Year at -12.89%, 6 Month at 33.76%, 3 Month at 21.45% and 1 Month at -16.22%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.